Humana Inc.
09/03/2024 | Press release | Distributed by Public on 09/03/2024 05:28
Regulation FD Disclosure Form 8 K
Item 7.01 Regulation FD Disclosure.
Members of Humana Inc.'s (the "Company") senior management team are scheduled to meet with investors and analysts at industry conferences and various other meetings between September 3, 2024 and September 30, 2024. During these conferences and meetings, the Company intends to reaffirm its guidance of approximately $12.81 in diluted earnings per common share ("EPS") or approximately $16.00 in adjusted earnings per common share ("Adjusted EPS"), in each case for the year ending December 31, 2024 ("FY 2024"). This guidance is consistent with the guidance issued in Humana's press release dated July 31, 2024. The date and time of presentations to investors are available via the Investor Relations calendar of events on the Company's website at www.humana.com.
The Company has included Adjusted EPS in this current report, a financial measure that is not in accordance with Generally Accepted Accounting Principles ("GAAP"). Management believes that this measure, when presented in conjunction with the comparable measure of GAAP EPS, provides a comprehensive perspective to more accurately compare and analyze the Company's core operating performance over time. Consequently, management uses Adjusted EPS as a consistent and uniform indicator of the Company's core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Adjusted EPS should be considered in addition to, but not as a substitute for, or superior to, GAAP EPS. A reconciliation of GAAP EPS to Adjusted EPS follows:
| Diluted earnings per common share | FY 2024 Guidance |
| GAAP | approximately $12.81 |
| Amortization of identifiable intangibles | 0.50 |
| Put/call valuation adjustments associated with Company's non-consolidating minority interest investments | 1.65 |
| Impact of exit of employer group commercial medical products business | 1.21 |
| Value creation initiatives | 0.80 |
| Cumulative net tax impact of non-GAAP adjustments | (0.97) |
| Adjusted (non-GAAP) - FY 2024 projected | approximately $16.00 |
Cautionary Statement
This Current Report on Form 8-K includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, generally including the words or phrases like "expects," "believes," "anticipates," "intends," "likely will result," "estimates," "projects" or variations of such words and similar expressions that are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the "Risk Factors" section of the Company's SEC filings.